Discovering The Potential Drug Target HAUS3 (G79441)

Target Name: HAUS3

NCBI ID: G79441

HAUS3

Discovering The Potential Drug Target HAUS3

Haaus3 (HAUS augmin like complex subunit 3) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a key component of the haematopoietic system, which is responsible for the production and maintenance of blood cells. The haematopoietic system is critical for the survival of the human body, and it is abnormalities in this system have been associated with a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Recent studies have identified HAUS3 as a potential drug target or biomarker for a number of different diseases. In this article, we will explore the biology of HAUS3, its potential as a drug target, and the research that has been done to study it.

The biology of HAUS3

HAUS3 is a member of the augmin like complex (ALC), which is a family of proteins that are involved in a variety of cellular processes, including cell signaling, DNA replication, and metabolism. The ALC is composed of several subunits, including HAUS1, HAUS2, and HAUS3, which each have distinct functions.

HAUS3 is a 21 kDa protein that is expressed in the brain, heart, and kidneys. It is highly conserved, with a calculated pI of 11.5, and it is expressed in a variety of tissues, including the blood, spleen, heart, and brain . HAUS3 is involved in the development and maintenance of blood cells, and it has been implicated in the development and progression of a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Potential drug targets

HAUS3 is a protein that has been identified as a potential drug target or biomarker for a number of different diseases. One of the main targets for HAUS3 is the neurodegenerative disease, Alzheimer's disease. Alzheimer's disease is a progressive neurodegenerative disorder that is characterized by the accumulation of neurofibrillary tangles and beta-amyloid plaques in the brain. These tangles and plaques are thought to contribute to the destruction of nerve cells in the brain, leading to the symptoms of Alzheimer's disease.

HAUS3 has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease. For example, studies have shown that HAUS3 is expressed in the brains of individuals with Alzheimer's disease, and that it is involved in the development and progression of the disease. Additionally, studies have shown that inhibiting HAUS3 can protect against the development and progression of neurodegenerative diseases, including Alzheimer's disease.

Another potential drug target for HAUS3 is the cancer. Cancer is a leading cause of death in the world, and it is characterized by the rapid growth and division of cells that can proliferate uncontrollably. The haematopoietic system is involved in the production and maintenance of blood cells, and it is thought to play a role in the development and progression of cancer.

Studies have shown that HAUS3 is involved in the development and progression of

Protein Name: HAUS Augmin Like Complex Subunit 3

Functions: Contributes to mitotic spindle assembly, maintenance of centrosome integrity and completion of cytokinesis as part of the HAUS augmin-like complex

The "HAUS3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HAUS3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets